By Denny Jacob
Perspective Therapeutics named Juan Graham as chief financial officer.
The Seattle-based radiopharmaceutical company on Monday said Jonathan Hunt will no longer serve as CFO in connection with the change but will continue to serve as its chief accounting officer.
Graham previously served as CFO of FibroGen, an emerging biopharmaceutical company.
Perspective will pay Graham an annual base salary of $500,000, and he will be eligible for an annual bonus based on a target bonus opportunity of 40% of the salary. Graham will also receive a one-time signing bonus of $80,000 and an equity grant of options to purchase 400,000 shares of the company's common stock, according to a securities filing.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
January 06, 2025 08:26 ET (13:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.